ACTG
Acacia Research Corporation
ACTG has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has a slight edge over ACTG overall, supported by stronger fundamentals and stronger modeled upside.
ACTG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Strong |
ACTG's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ACTG PE Valuation
ACTG has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ACTG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect ACTG's losses to shrink, with revenue growing.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ACTG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.19 | -480% |
| Q2 2026 | -$0.16 | -$0.10 |
| Q1 2026 | -$0.19 | -$0.08 |
| Q4 2025 | $0.22 | +$0.58 |
| Q3 2025 | $0.05 | -94% |
| Q2 2025 | -$0.06 | -106% |
| Q1 2025 | -$0.11 | -117% |
| Q4 2024 | -$0.36 | -162% |
ACTG has swung to a loss: it lost $0.19 per share over the past year, after a profit the year before.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB has the edge over ACTG on earnings, with more consistent year-over-year improvement.
ACTG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.4M | -8.4% |
| Q2 2026 | $114.6M | +124% |
| Q1 2026 | $54.2M | -56% |
| Q4 2025 | $50.1M | +2.6% |
| Q3 2025 | $59.4M | +155% |
| Q2 2025 | $51.2M | +98% |
| Q1 2025 | $124.4M | +412% |
| Q4 2024 | $48.8M | -47% |
ACTG's revenue fell from its 2025 peak and has held roughly level since: $54M last quarter, down 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.6% | +4.2 points |
| Q2 2026 | 7.4% | +32 points |
| Q1 2026 | -15% | -46 points |
| Q4 2025 | -26% | +6.3 points |
| Q3 2025 | -11% | +33 points |
| Q2 2025 | -24% | -5.8 points |
| Q1 2025 | 31% | +39 points |
| Q4 2024 | -32% | -95 points |
ACTG has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ACTG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ACTG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15M | +57% |
| Q2 2026 | $3.9M | -92% |
| Q1 2026 | $3.4M | +916% |
| Q4 2025 | $13.2M | +$36.7M |
| Q3 2025 | $9.5M | +$12.4M |
| Q2 2025 | $50.1M | +$176.9M |
| Q1 2025 | $335K | -99% |
| Q4 2024 | -$23.6M | -$19M |
ACTG has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ACTG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -15.9x | Net Cash |
| Q2 2026 | -12.8x | Net Cash |
| Q1 2026 | -222.7x | Net Cash |
| Q4 2025 | -4.3x | Net Cash |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -4.9x | Net Cash |
| Q1 2025 | -3.5x | Net Cash |
| Q4 2024 | -246.8x | Net Cash |
ACTG has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACTG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 22.5 | Neutral |
ACTG's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ACTG PE vs Industrials Sector
| Metric | ACTG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ACTG has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ACTG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.26 | 2.3% below |
| 20 week MA | $4.44 | 6.3% below |
| 50 week MA | $4.41 | 5.7% below |
| 100 week MA | $4.04 | 3% above |
| 200 week MA | $4.19 | 0.7% below |
ACTG's trend is mixed: it's above one of its five weekly moving averages, and 0.7% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over ACTG on trend strength, trading above more of its moving averages.
ACTG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.67 | $4.10 | +54% |
| 2021 | $4.10 | $5.23 | +28% |
| 2022 | $5.23 | $3.98 | -24% |
| 2023 | $3.98 | $3.92 | -1.5% |
| 2024 | $3.92 | $4.37 | +11% |
| 2025 | $4.37 | $3.73 | -15% |
| 2026 YTD | $3.73 | $4.16 | +12% |
ACTG has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.